Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q1 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.